Completed Enrollment

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab (ADapt)

J2T-MC-KGBO -

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) previously treated with Dupilumab.

Trial Summary

Age Range
≥12 years
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
Lebrikizumab
Could I receive a Placebo?
No
Enrollment Goal
120
Trial Dates
Dec 19, 2022 - Dec 2024
How long will I be in the trial?
The study will last about 38 weeks and may include up to 10 visits.
Trial Phase
III

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have taken dupilumab previously for at least 4 months

  • Have had atopic dermatitis for over a year

  • Had little improvement with topical medicines

  • Weigh over 40 kilograms at study start

Participants Must Not:

  • Had HIV

  • Other infections such as Hepatitis B or C

  • Uncontrolled asthma

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources

Immunology  Research

Click the below button to learn more about our autoimmune disease research and clinical trials.

Learn More

Learn About Our Pediatric Research

With the help of research study participants, we are learning about pediatric conditions and potential new approaches to treating disease.

Learn More

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.